Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
:0H9X
0H9X Analyst Ratings
Hold
3 Buy
8 Hold
3 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0H9X Stock 12 Month Forecast
Average Price Target
€45.69
▲(6.98% Upside)
| Highest Price Target€55.00 | Average Price Target€45.69 | Lowest Price Target€33.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Goldman Sachs
Reiterated
03/12/25
Bernstein
Reiterated
03/04/25
Jefferies
Reiterated
03/04/25
Morgan Stanley
Reiterated
02/27/25
DZ BANK AG
Upgraded
02/27/25
Barclays
Reiterated
02/26/25
Deutsche Bank
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/25/25
Warburg Research
Reiterated
02/25/25
J.P. Morgan
€37.3→€41.5
Sell
-2.83%
Downside
Reiterated
02/25/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan
Kepler Capital
€47
Hold
10.04%
Upside
Reiterated
02/25/25
Kepler Capital Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank
€55
Buy
28.78%
Upside
Reiterated
01/30/25
Berenberg Bank Sticks to Its Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi
€41→€46.5
Hold
8.87%
Upside
Reiterated
01/28/25
Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR46.50 at CitiCiti analyst Veronika Dubajova raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR46.50 (from EUR41.00) while maintaining a Neutral rating.
HSBC
€37→€48
Buy
12.39%
Upside
Upgraded
12/04/24
HSBC Upgrades Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) to BuyHSBC analyst Sezgi Oezener upgraded Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) from Hold to Buy with a price target of EUR48.00 (from EUR37.00).
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
Reiterated
03/12/25
Bernstein
Reiterated
03/04/25
Jefferies
Reiterated
03/04/25
Morgan Stanley
Reiterated
02/27/25
DZ BANK AG
Upgraded
02/27/25
Barclays
Reiterated
02/26/25
Deutsche Bank
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/25/25
Warburg Research
Reiterated
02/25/25
J.P. Morgan
€37.3→€41.5
Sell
-2.83%
Downside
Reiterated
02/25/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan
Kepler Capital
€47
Hold
10.04%
Upside
Reiterated
02/25/25
Kepler Capital Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank
€55
Buy
28.78%
Upside
Reiterated
01/30/25
Berenberg Bank Sticks to Its Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi
€41→€46.5
Hold
8.87%
Upside
Reiterated
01/28/25
Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR46.50 at CitiCiti analyst Veronika Dubajova raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR46.50 (from EUR41.00) while maintaining a Neutral rating.
HSBC
€37→€48
Buy
12.39%
Upside
Upgraded
12/04/24
HSBC Upgrades Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) to BuyHSBC analyst Sezgi Oezener upgraded Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) from Hold to Buy with a price target of EUR48.00 (from EUR37.00).
Best Analysts Covering Fresenius Medical Care AG & Co. KGaA
Which Analyst Should I Follow If I Want to Buy GB:0H9X and Sell After:
1 Month
xxx
Success Rate
12/20 ratings generated profit
Average Return
+3.13%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +3.13% per trade.
3 Months
xxx
Success Rate
15/20 ratings generated profit
Average Return
+7.28%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +7.28% per trade.
1 Year
Success Rate
14/20 ratings generated profit
Average Return
+10.41%
reiterated a buy rating last month
Copying Victoria Lambert's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +10.41% per trade.
2 Years
xxx
Success Rate
17/20 ratings generated profit
Average Return
+16.99%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.00% of your transactions generating a profit, with an average return of +16.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0H9X Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
5
7
9
8
6
Hold
12
17
23
22
19
Sell
13
13
10
12
10
Strong Sell
0
0
0
0
0
total
30
37
42
42
35
Each month's total comprises the sum of three months' worth of ratings.
0H9X Financial Forecast
0H9X Stock Forecast FAQ
What is GB:0H9X’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is €45.69.
What is GB:0H9X’s upside potential, based on the analysts’ average price target?
Fresenius Medical Care AG & Co. KGaA has 6.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
Fresenius Medical Care AG & Co. KGaA has a consensus rating of Hold, which is based on 3 buy ratings, 8 hold ratings and 3 sell ratings.
What is Fresenius Medical Care AG & Co. KGaA’s share price target?
The average share price target for Fresenius Medical Care AG & Co. KGaA is €45.69. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €55.00 ,and the lowest forecast is €33.00. The average share price target represents 6.98% Increase from the current price of €42.71.
The highest analyst share price target is €55.00 ,and the lowest forecast is €33.00. The average share price target represents 6.98% Increase from the current price of €42.71.
What do analysts say about Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
To buy shares of GB:0H9X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.